Express Healthcare

POC Medical Systems collaborates with Ushalakshmi Breast Cancer Foundation

324

They have launched a pan India multi centre breast cancer screening trial ‘MammoAlert’ which is based upon disruptive technology

From Left to Right: Dr Smita Singhania, Dr. P. Raghu Ram, Padma Shri awardee, CEO and Director, Ushalakshmi Breast Cancer Foundation, Ms Lakshmi Manchu, Actor, Producer & Television host, Mr Ramana Tadepalli, Board Director, POC Medical Systems, Mr Sanjeev Saxena, Managing Director, POC Medical Systems Inc, Dr Smita Singhania
From Left to Right: Dr Smita Singhania, Dr. P. Raghu Ram, Padma Shri awardee, CEO and Director, Ushalakshmi Breast Cancer Foundation, Ms Lakshmi Manchu, Actor, Producer & Television host, Mr Ramana Tadepalli, Board Director, POC Medical Systems, Mr Sanjeev Saxena, Managing Director, POC Medical Systems Inc, Dr Smita Singhania

POC Medical Systems, California and Ushalakshmi Breast Cancer Foundation, Hyderabad, a not for profit Breast cancer charity has announced collaboration to launch pan India multi centre breast cancer screening trial based upon disruptive technology ‘MammoAlert’– a rapid, low cost, accurate blood test’.

Dr P Raghu Ram, CEO, Ushalakshmi Breast Cancer Foundation & Director, KIMS- Ushalakshmi centre for breast diseases will be spearheading this clinical trial as pan india principal investigator. The study design involves looking at activity of panel of four Breast cancer specific biomarkers in a blood sample collected from women presenting with newly diagnosed breast cancers to seven Cancer Centres spread across India. KIMS-Hospitals & Indo American Cancer Centre, Hyderabad, Manipal Hospitals, Bengaluru, Tata Medical Centre, Kolkata, Maulana Azad Medical College, New Delhi, Amrita Institute of Medical Sciences, Kochi & HCG Cancer Centre, Ahmedabad, would be participating in this study to assess the accuracy of this blood test.

According to the company’s release, since beginning of June 2017, more than 100 patients have already been recruited in this trial. The clinical study will help POC Medical Systems to revalidate the technology in Indian patients and get accurate India centric data. This data exercise would also be a stepping stone towards designing & implementing a population based Breast Cancer Screening programme in the rural areas all across India in collaboration with Ushalakshmi Breast Cancer Foundation.

This portable breast cancer screening test uses a simple drop of blood to generate results in 15 minutes. It does not require expensive equipment or expertise to generate the result. In the Studies done thus far, the MammoAlert has demonstrated an accuracy of over 95 per cent and a false positive rate of zero. This disruptive technology will hopefully have a huge social impact enabling thousands of women in India to detect breast cancer in its early stage as this test is simple, low cost and accurate.

- Advertisement -

Comments are closed.